CTLA-4 (Ipilimumab Biosimilar) anticorps (Biotin)

N° du produit ABIN7607823

Cet anticorps anti-CTLA-4 (Ipilimumab Biosimilar) est un anticorps Human Monoclonal détectant CTLA-4 (Ipilimumab Biosimilar) dans FACS et ELISA. Adapté pour Humain.

Aperçu rapide pour CTLA-4 (Ipilimumab Biosimilar) anticorps (Biotin) (ABIN7607823)

Antigène: CTLA-4 (Ipilimumab Biosimilar)

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CTLA-4 (Ipilimumab Biosimilar) est conjugé à/à la Biotin

Application: Flow Cytometry (FACS), ELISA

Détail du produit anti-CTLA-4 (Ipilimumab Biosimilar) anticorps (Biotin)

Fonction: Biotinylated Anti-CTLA-4 (ipilimumab biosimilar) mAb

Isotype: IgG1

Information d'application

Indications d'application: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Détails sur CTLA-4 (Ipilimumab Biosimilar)

Antigène: CTLA-4 (Ipilimumab Biosimilar)

Autre désignation: ipilimumab Biosimilar

Classe de substances: Biosimilar

Sujet: Synonyms Target:CTLA4,CD152
Synonyms Antibody:BMS-734016, MDX-010, MDX-CTLA-4